Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-01-17 @ 2:35 PM
Study NCT ID:
NCT02639234
Status:
WITHDRAWN
Last Update Posted:
2017-07-31
First Post:
2015-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer
Sponsor:
Gradalis, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
None
Primary Completion Date:
2017-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-21
First Submit QC Date:
None
Study First Post Date:
2015-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-27
Last Update Post Date:
2017-07-31
Last Update Post Date Type:
ACTUAL